Literature DB >> 19029525

4-aminopyridine toxicity with unintentional overdose in four patients with multiple sclerosis.

Jodie M Burton1, Chaim M Bell, Scott E Walker, Paul W O'Connor.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19029525     DOI: 10.1212/01.wnl.0000339380.23073.58

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  7 in total

Review 1.  [4-Aminopyridine (Fampridine). A new attempt for the symptomatic treatment of multiple sclerosis].

Authors:  L Husseini; V I Leussink; B C Kieseier; H-P Hartung
Journal:  Nervenarzt       Date:  2010-02       Impact factor: 1.214

Review 2.  4-aminopyridine toxicity: a case report and review of the literature.

Authors:  Andrew M King; Nathan B Menke; Kenneth D Katz; Anthony F Pizon
Journal:  J Med Toxicol       Date:  2012-09

Review 3.  Description of outbreaks of health-care-associated infections related to compounding pharmacies, 2000-12.

Authors:  Catherine Staes; Jason Jacobs; Jeanmarie Mayer; Jill Allen
Journal:  Am J Health Syst Pharm       Date:  2013-08-01       Impact factor: 2.637

Review 4.  Restoring Axonal Function with 4-Aminopyridine: Clinical Efficacy in Multiple Sclerosis and Beyond.

Authors:  Verena Isabell Leussink; Xavier Montalban; Hans-Peter Hartung
Journal:  CNS Drugs       Date:  2018-07       Impact factor: 5.749

5.  Impact of extended-release dalfampridine on walking ability in patients with multiple sclerosis.

Authors:  Keith C Hayes
Journal:  Neuropsychiatr Dis Treat       Date:  2011-04-28       Impact factor: 2.570

6.  Dalfampridine sustained-release for symptomatic improvement of walking speed in patients with multiple sclerosis.

Authors:  Douglas R Jeffery; Emily Poole Pharr
Journal:  Core Evid       Date:  2010-12-08

7.  Prolonged Toxic Encephalopathy following Accidental 4-Aminopyridine Overdose.

Authors:  Maria Ballesta Méndez; Vincent van Pesch; Arnaud Capron; Philippe Hantson
Journal:  Case Rep Neurol Med       Date:  2014-04-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.